FAM96B Activators
FAM96B Activators are an assorted set of chemical compounds that indirectly bolster the functional activity of FAM96B through diverse signaling pathways in the cellular milieu. Compounds like Forskolin and Ionomycin activate protein kinases such as PKA and calcium-dependent proteins that may phosphorylate substrates or components in pathways where FAM96B is implicated, thus enhancing its activity. LY294002 and Sodium orthovanadate could shift the signaling equilibrium to pathways involving FAM96B,The specific chemical compounds that serve as indirect FAM96B Activators facilitate the enhancement of FAM96B's functional activity by modulating distinct cellular signaling pathways. Forskolin activates protein kinase A (PKA), which may phosphorylate proteins in pathways that FAM96B is a part of, thus enhancing its activity. Epigallocatechin gallate acts as a kinase inhibitor, reducing inhibitory phosphorylation that affects FAM96B's function. Ionomycin and A23187, as calcium ionophores, increase intracellular calcium levels, potentially activating calcium-dependent pathways that influence FAM96B's activity. Sodium orthovanadate could maintain the phosphorylation state of proteins within FAM96B's pathways, indirectly enhancing its activity. Resveratrol may promote FAM96B activity by inducing deacetylation processes that are beneficial for its function.
In continuation, LY294002 may redirect signaling towards pathways that include FAM96B, enhancing its function. Trichostatin A could alter gene expression patterns in a way that indirectly promotes FAM96B's role. SB203580 and U0126, as inhibitors of p38 MAPK and MEK1/2, respectively, could shift signaling dynamics away from competing pathways, favoring the activation of FAM96B. PD98059, another MEK inhibitor, may similarly enhance FAM96B activity by dampening competing signaling routes. Thapsigargin, by inhibiting the SERCA pump, disrupts calcium homeostasis, which could lead to the activation of calcium-dependent pathways, enhancing FAM96B's functional role. Collectively, these compounds, through their targeted effects on cellular signaling, facilitate the enhancement of FAM96B's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a kinase inhibitor that may enhance FAM96B activity by inhibiting kinases that negatively regulate pathways FAM96B is involved in, thereby reducing inhibitory phosphorylation events. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent proteins and pathways, possibly leading to an enhanced functional state of FAM96B through calcium signaling cascades. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate acts as a phosphatase inhibitor, which could prevent the dephosphorylation of proteins within pathways FAM96B is involved in, thus maintaining an activated state of those pathways and potentially FAM96B. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuin proteins, which can lead to deacetylation of target proteins. This process may indirectly enhance the functional activity of FAM96B if it relies on deacetylation for its activation or interaction with other cellular components. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore, similar to Ionomycin, that increases intracellular calcium levels, potentially enhancing FAM96B activity by activating calcium-dependent signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may enhance FAM96B by reducing competitive signaling pathways, effectively shifting the balance toward pathways where FAM96B is active. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that could indirectly influence FAM96B activity by altering chromatin structure and affecting the cellular context in which FAM96B functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor that could shift cellular signaling towards pathways that FAM96B is involved in, thereby potentially enhancing FAM96B's activity by reducing the phosphorylation of competing substrates. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an MEK inhibitor that could indirectly enhance the activity of FAM96B by dampening the MAPK pathway, which may favor the activation of pathways involving FAM96B. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pump, potentially increasing the activity of FAM96B through enhanced calcium signaling pathways. | ||||||